Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

Experts caution that this review is not a sign that infant formula is dangerous. Here's what parents should be aware of.

News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, ...

The new bill extends previous legislation, codifying how clinics can provide access to drugs that have only been through ...

Experts are sounding the alarm about increased use of kratom and about highly concentrated products containing 7-OH, a more ...

Ozempic was approved to treat Type 2 diabetes in 2017, and it’s become increasingly popular among those who don’t have the ...

A North Texas woman with a cautionary tale warns others to do their research before starting popular weight loss drugs.

Analyzing the permissible scope of an injunction under the Hatch-Waxman Act, the US Court of Appeals for the Federal Circuit reversed the ...

A law professor’s new study finds that advertisers may be using patent and FDA approval claims to make their products seem ...

The U.S. Food and Drug Administration has approved Amneal Pharmaceuticals' self-administered migraine drug, giving way to a ...